Disciplined Investments, LLC Vertex Pharmaceuticals Inc Transaction History

Disciplined Investments, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$283.23 - $323.1 $566 - $646	-2 Reduced 12.5%	14 $4,000
Q4 2022 Feb 01, 2023	SELL	$285.76 - $321.48 $571 - $642	-2 Reduced 11.11%	16 $4,000
Q3 2022 Nov 03, 2022	BUY	$273.83 - $305.53 $273 - $305	1 Added 5.88%	18 $5,000
Q2 2022 Aug 09, 2022	BUY	$234.96 - $292.55 $469 - $585	2 Added 13.33%	17 $5,000
Q1 2022 Apr 22, 2022	BUY	$221.42 - $260.97 $3,321 - $3,914	15 New	15 $4,000

1,716

225M

1.19M

1.56M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Disciplined Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Disciplined Investments, LLC with notifications on news.